MedPath
NMPA Approval

Certolizumab Pegol Injection

国药准字SJ20190031

August 8, 2024

S20190031

Drug Information

培塞利珠单抗注射液

希敏佳

注射剂

200mg(1.0ml)/支(预充式注射器)

生物制品

August 8, 2024

March 24, 2029

Company Information

Applicant Company

UCB PHARMA SA

Allée de la Recherche 60, B-1070 Bruxelles, Belgium

Manufacturing Company

Eisenbahnstrasse 2-4, 88085 Langenargen, Germany

© Copyright 2025. All Rights Reserved by MedPath
培塞利珠单抗注射液 - NMPA 批准文号 | MedPath